FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease
The FDA approved the first cell-based gene therapies, Casgevy and Lyfgenia, for the treatment of sickle cell disease in patients 12 years and older.
The FDA approved the first cell-based gene therapies, Casgevy and Lyfgenia, for the treatment of sickle cell disease in patients 12 years and older.
Chronic myelomonocytic leukemia (CMML) is an aggressive clonal stem cell disorder categorized amongst myelodysplastic/myeloproliferative (MDS/MPN) overlap neoplasms. While sharing features with both MDS and MPN,…
Individuals ineligible for ADHD medication trials face higher risks of adverse outcomes. This study provides the first empirical evidence for the limited generalisability of ADHD…
Background Standardised Diagnostic Assessment tools, such as the Development and Well-Being Assessment (DAWBA), may aid detection and diagnosis of emotional disorders but there is limited…
Background Identifying clusters of multiple long-term conditions (MLTCs), also known as multimorbidity, and their associated burden may facilitate the development of effective and cost-effective targeted…
To truly learn from this case, we must accept that the crimes of Dominique Pelicot were not committed in a vacuum.
Dr Tim Cooksley, a consultant in acute medicine, says the Prime Minister risks an ‘eternal crisis’ in the NHS without urgent social care and workforce…
French president accuses world’s richest man of intervening directly in continent’s democratic processes
The outgoing surgeon general will have to rely on Congress and the next administration to add warnings about cancer risks to alcohol labels.
Some ultra-processed foods are better for you than others. Use this guide to find them.
The government pledged to cut the list of patients waiting more than 18 weeks for treatment in England by nearly half a million over the…